Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2022-12-23

Genetic Diversity of HLA in Europe : Impact on Transplantation and Preventive Medicine

Objective



The histocompatibility antigens play a crutial role in normal and pathological immune processes. There are two classes of the antigens. The class I is expressed by every cell and present the endogen peptides. to immune cells for eliminate malignant or infected cells. The class II antigens serve for presentation of processed exogen peptides and is expressed in restricted number of cells - antigen presenting cells. Both classes are coded by several gens, which cluster in two regions, according to their functions. This two clusters are divided by only one megabase gap and however have different patterns of expression: while class I is ubiquitous, class II is expressed by particular cell at particular developmental stage.
There are some examples of multilevel regulation by chromatine conformation of gens clusters in man, beta-globin claster is the better known. Chromatin folding and unfolding accomplished during cell development is the mechanism of "opening" or "shut douw" of expression, and precede its initiation. The changes in chromatin conformation are regulated by locus control region, already described in several human clasters, but not in the class I or II region.
Taking in account the pathology, followed by complete absence of class II expression we proposed to study the process of normal and pathological inactivation of class II gens in several molecular models.
The knowledge of class II regulation at the chromatin level will promote our comprehension of bare lymphocyte syndrom and autoimmunity, will also fernish new approach of improvement of immune response against infection.
We propose also a new and simple method to test the locus control region capacity, which can be applied in any situation, when gen transfection is needed.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

HLA ET MDECINE
EU contribution
No data
Address
Rue de l'Ecole de MTdecine 15, Institut BiomTdical
75006 PARIS
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0